Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in recurrent ovarian or peritoneal cancer
NCT00459290Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- May 2007
- Primary completion
- Jul 2010
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in ovarian epithelial carcinoma, primary peritoneal carcinoma (PPC), fallopian tube carcinoma (PFTC), sponsored by GOG Foundation. Started May 2007; status: completed.
02
Drugs
mifepristone
03
Conditions
ovarian epithelial carcinomaprimary peritoneal carcinoma (PPC)fallopian tube carcinoma (PFTC)
Beyond the preview
Go deeper on NCT00459290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459290.